Back to search
Platelet Refractoriness
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Platelet Refractoriness trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Platelet Refractoriness trials you may qualify forThis is a randomized, open-label, phase IB/II clinical study to evaluate the safety and preliminary efficacy of CM313(SC) injection in patients with Platelet Tr…
Due to long-term dependence on platelet transfusion, some severe aplastic anemia (SAA) patients suffer platelet transfusion refractoriness (PTR). Unlike immune…
Background: Platelets are blood cells that help blood clot. Some people have what is called thrombocytopenia. This means they have a low blood platelet count.…
Platelet Transfusion Refractoriness is one of the severe complications after multiple transfusions in patients with severe thrombopenia. Platelet Transfusion Re…
Platelet transfusions are widely employed to prevent or treat bleeding episodes in patients with thrombocytopenia. Patients with bone marrow failure secondary t…